  Dose reduction in obese cancer patients has been replaced by fully weight-based dosing recommendations. No data , however , are available on the effects of dose reduction in obese stage III colon cancer patients undergoing adjuvant chemotherapy. Survival outcomes and toxicity data of obese ( body mass index ( BMI) ≥ 30 kg/m 13.4 % ( 280 of 2094 patients) had a BMI ≥ 30 kg/m Data support the recommendation of using fully dosed chemotherapy for the adjuvant treatment in obese patients with colon cancer.